Management of Adult Renal Tumours: Review of Nine (9) Years Experience

Ngwobia Peter Agwu, Abdullahi Khalid, Uzodimma Ejike Onwuasoanya, Abdullahi Abdulwahab-Ahmed, Abubakar Sadiq Muhammad, Saddik Malam Sahabi and Ismaila Arzika Mungadi
Additional contact information
Ngwobia Peter Agwu: Usmanu Danfodiyo University Teaching Hospital, Nigeria
Abdullahi Khalid: Usmanu Danfodiyo University Teaching Hospital, Nigeria
Uzodimma Ejike Onwuasoanya: Usmanu Danfodiyo University Teaching Hospital, Nigeria
Abdullahi Abdulwahab-Ahmed: Usmanu Danfodiyo University Teaching Hospital, Nigeria
Abubakar Sadiq Muhammad: Usmanu Danfodiyo University Teaching Hospital, Nigeria
Saddik Malam Sahabi: Usmanu Danfodiyo University Teaching Hospital, Nigeria
Ismaila Arzika Mungadi: Usmanu Danfodiyo University Teaching Hospital, Nigeria

European Journal of Medical and Health Sciences, 2020, vol. 2, issue 5

Abstract: Background: Renal tumours appear to be relatively uncommon in our routine urological practice compared to other urological malignancies of bladder and prostate origins. Their presentations are often late despite increasing availability and affordability of routine imaging modalities for early detection. This therefore poses management challenge in our environment. This study aims to review our 9-year experience with the management of renal tumours at the Urology Unit of a tertiary health facility in North-western Nigeria Methodology: A retrospective review of 20 patients managed for renal tumour at our facility from September 2009 to August 2017. Data of all adult patients managed for renal tumours was retrieved and analyzed using SPSS 20.0 version for windows. The results were presented in percentages and mean ± SD as well as charts. Results: Twenty (20) patients were managed for renal tumours during the review period. The mean age of patients was 39.94 ± 12.19 years with median of 35 years and male to female ratio of 1:2. Nineteen (19) patient (95%) and 1(5%) had malignant and benign renal tumours respectively. Clinical presentations were flank mass seen in 18 patients (90%), flank pain 16 (80%), haematuria 10(50%), cough 2(10%), and pleural effusion 2(10%). Only clinical stages III and IV tumour were seen. 70% were clear cell variety while 5% was angiomyolipoma. Sixteen (80%) of patients had radical nephrectomy and two (10%) with inoperable tumour benefited from targeted molecular therapy preoperatively using Sorafenib. Conclusion: Late presentation of patients with renal tumours to our facility despite the availability of imaging facilities such as ultrasound scanning is still the norm. This makes surgery which offers best chance of survival and quality of life difficult and challenging. Targeted therapy using sorafenib, if available and affordable in our environment will be useful in management of patients with inoperable tumours.

Keywords: Renal tumours; experience; late presentation; management (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejmed/article/view/40515 Abstract page (text/html)
https://eu-opensci.org/index.php/ejmed/article/download/40515/9021 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejmed0:v:2:y:2020:i:5:id:40515

DOI: 10.24018/ejmed.2020.2.5.515

Access Statistics for this article

More articles in European Journal of Medical and Health Sciences from European Open Science
Bibliographic data for series maintained by Support ().